Overview

Steven Zelenkofske and Jim Roach address the role of the CMO

The Conference Forum\’s 3rd Annual Chief Medical Officer Summit for Emerging Life Science Companies is delighted to present a truly distinctive and interactive event for CMOs. We are grateful to Dr. Elizabeth Stoner, Managing Director, MPM Capital, for suggesting the idea and to our CMO advisers for their insights on content and agenda development.

We are Dedicated to Accomplishing Two Goals

1. To bring together CMO executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital, working and meeting with investors and strategizing for appropriate exits.
2. To create a network of CMOs from small to mid-size life science companies to share ideas, solutions and support.

Ken Getz, featured speaker at the Summit, with Valerie Bowling, TCF

The Role of a CMO in Emerging Life Science Companies
The role of a Chief Medical Officer is one that means many things to many people, and indeed is radically different depending on the type of organization in which a CMO works. For CMOs in early, emerging and even mid-size life science companies, the role can be an isolated one, but with all the responsibility for driving the clinical development and CRO management while meeting the needs of investors and positioning for an appropriate exit. Chief Medical Officers  are playing an increasingly larger role in raising funding for their life science companies.

Women CMOs networking

Who Should Attend
The conference is designed specifically for CMOs, but certainly Heads of R&D, CSOs, Clinical Operations/Development/Outsourcing, and Vice Presidents of Medical Affairs would also greatly benefit from attending the program. Clinical service providers and investors are encouraged to attend as conversations with CMOs are very much welcomed.

Testimonials

• \’I think that CMOs can and should play a bigger and more overt role in running companies. As such it is important to me that they feel empowered and trained to do so.\’

  – Lauren Silverman, PhD, Managing Director, Novartis Venture Funds

• \’I found the meeting extremely useful since it was designed exclusively to addressing CMO interests. The opportunity to network with my peers at this event was invaluable since, barring this meeting, interactions I have with my peers tend to be at scientific meetings where the focus is the scientific meeting and not the CMO peer interactions.\’

  – Santosh Vetticaden, PhD, MD, CMO, SVP, Mast Therapeutics, Inc.